Gene Manipulation in Living Cells
Sigma-Aldrich and Sangamo Biosciences have partnered to exploit an interventional technology in genome science for the development of new material for cell-based assays.
“Using a zinc finger nuclease-based approach we are now able to engineer the genome of living cells,” states David Smoller, Ph.D., president of the research biotechnology business unit at Sigma-Aldrich.
The CompoZr™ zinc finger nuclease (ZFN) technology for targeted genome editing allows the insertion, deletion, or alteration of targeted sequences, including the placement of a reporter gene in front or at the 3´ end of any endogenous locus that the investigator may choose.
The technology is modular—the zinc finger domain targets to a specific sequence and the heterodimeric nuclease cleaves the genomic DNA, creating a double-stranded break. This break in the DNA stimulates the natural repair mechanisms of the cell, allowing an exogenous transfected DNA sequence to be integrated into the region of interest in the genome.
The CompoZr ZFN system allows the investigator to engineer a wide range of possibilities for custom cell lines to be used in cell-based assays. The procedure is fast and straightforward, and because it can be performed on living cells, it would lend itself especially to redesigning embryos, including Drosophila, zebrafish, mice, and other important molecular model systems.